Immediate Impact
2 from Science/Nature 82 standout
Citing Papers
SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples
2022 Standout
Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C
2022 Standout
Works of Gerald Moritz being referenced
Information on new drugs at market entry: retrospective analysis of health technology assessment reports versus regulatory reports, journal publications, and registry reports
2015
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Gerald Moritz | 517 | 178 | 352 | 384 | 38 | 1.1k | |
| Chuan Xu | 269 | 37 | 217 | 92 | 34 | 926 | |
| Helen Griffiths | 106 | 33 | 669 | 124 | 58 | 1.3k | |
| Valéry Hédouin | 780 | 125 | 117 | 67 | 95 | 1.4k | |
| Matthew Wallace | 275 | 200 | 118 | 467 | 72 | 1.3k | |
| Eric C. Chen | 84 | 64 | 507 | 221 | 44 | 1.2k | |
| Joshua P. White | 278 | 139 | 391 | 36 | 21 | 1.0k | |
| Maureen Carter | 234 | 199 | 167 | 103 | 52 | 1.2k | |
| Pierre Fontanillas | 107 | 184 | 321 | 90 | 33 | 1.4k | |
| J. C. Watt | 284 | 692 | 132 | 100 | 82 | 1.2k | |
| Benjamin D. Aronson | 83 | 33 | 546 | 59 | 36 | 1.3k |
All Works
Login with ORCID to disown or claim papers
Loading papers...